//LiRIS® Clinical Trial Launched in USA & Canada

LiRIS® Clinical Trial Launched in USA & Canada

A new research study is being conducted at investigational sites in the US and Canada for women diagnosed with Interstitial Cystitis. The purpose of this study is to determine the safety, effectiveness and tolerability of an investigational product that delivers the drug lidocaine continuously over 14 days directly into the bladder. Known as LiRIS® , the product is a soft silicone tube containing lidocaine that is placed in the bladder using standard urological procedures in the urologist’s office and then is removed 14 days later. This study compares the lidocaine system with a placebo system, the same silicone tube with no active drug.

The study requires participants to complete up to five clinic visits and two phone calls over an eight week period. You may be eligible to participate in this study if you are a female 18 years of age or older, diagnosed with Interstitial Cystitis, and experiencing bladder pain, along with additional criteria. Sponsor: TARIS Biomedical, Inc.

Research Centers in the USA 

  • Arizona, Glendale – Clinical Trials of Arizona – Contact: Bridget Gonzales 602-789-1650
  • California, Glendora – Citrus Valley Medical Research, Inc. – Contact: Lisa Regan 626-914-3295
  • California, Stanford – Stanford Univ. Dept. of Urology – Contact: Patricia Glowe 650-498-4240
  • Colorado, Denver – Genitourinary Surgical Consultants – Contact: Khalis Mitchell 303-320-0200
  • Connecticut, Farmington – Women’s Health Specialty Care – Contact: Madeline Vazquez 860-678-3491
  • Connecticut, New Britain – Grove Hill Clinical Research – Contact: Lihi Brocke PhD 860-801-6543
  • Florida, Bradenton – Manatee Medical Research Institute, LLC – Contact: Amy Boucher 941-792-0340
  • Idaho, Couer D’Alene – North Idaho Urology – Contact: Patti Patterson, RN 208-667-0621
  • Idaho, Meriden – Idaho Urologic Center – Contact: Shanna Vail 208-639-4938
  • Indiana, Jefferson – First Urology – Contact: Christina Dallas 812-206-8161
  • Louisiana, Shreveport – Regional Urology LLC – Contact: Connie Nalewaik 318-683-0411
  • Massachusetts, Burlington – Lahey Clinical Medical Center – Contact: Linda Toopjian 781-744-8711
  • Massachusetts, Watertown – Bay State Clinical Trials, Inc. – Contact: Debbie Cohen RN 617-923-0328
  • Michigan, Grand Rapids – Female Pelvic Medicine & Urogynecology – Contact: Beth Rogers 616-450-9598
  • Michigan, Royal Oak – William Beaumont Hospital – Contact: Maureen Cooney 248-551-9477
  • Mississippi, Jackson – CRC of Jackson and Southeast Urogynecology – Contact: Suzanne Griffith 601-714-3261
  • Nevada, Las Vegas – Sheldon Freedman MD Ltd – Contact: Emily Freedman 702-732-0282
  • New York, New Hyde Park – Arthur Smith Institute for Urology – Contact: Monica Johnson 516-734-8515
  • New York, Rochester – University of Rochester – Contact: Patricia Conway 585-276-3528
  • North Carolina, Greensboro – Alliance Urology Specialists – Contact: Michelle Utrera 336-232-5322
  • North Carolina, Winston-Salem – Wake Forest Univ. – Contact: Janet Shuping 336-716-2612
  • Ohio, Cleveland – MetroHealth Medical Center – Contact: Marilyn Alejandro-Rodriguez 216-778-8432
  • Oklahoma, Oklahoma City – Univ. of OK Health Science Ctr, Urology – Contact: Vickie Phillips 405-271-6900
  • Pennsylvania, Philadelphia – Penn. Presbyterian Medical Center – Contact: Mary Walicki, RN BSN 215-662-9633
  • South Carolina, Charleston – Medical Univ. of SC Urology – Contact: Jennifer M Bunch 843-792-2325
  • South Carolina, Myrtle Beach – Carolina Urologic Research Ctr. – Contact: Kimberly McKenzie 843-449-1010 ext 265
  • Tennessee, Nashville – Vanderbilt Univ. Medical Center – Contact: Brenda Hughes 615-343-0445
  • Washington, Mountlake Terrace – Integrity Medical Research – Contact: Anna Fierro 425-275-0680

Research Centers in Canada

  • Canada, British Columbia – Pacific Urological Research – Contact: Jayne Forster-Coull 250-388-0840
  • Canada, Ontario – Centre for Applied Urologic Research – Contact: Sylvia Robb, RN 613-548-7800

More centers will be added to the clinicaltrials.gov webpage in the future. If you are interested in finding out more about this study, please go to www.clinicaltrials.gov for more information and site locations near you.

By |2013-04-05T11:13:48+00:00June 8th, 2012|Uncategorized|Comments Off on LiRIS® Clinical Trial Launched in USA & Canada

About the Author:

My Google Profile+ Jill Heidi Osborne is the president and founder of the Interstitial Cystitis Network, a health education company dedicated to interstitial cystitis, bladder pain syndrome and other pelvic pain disorders. As the editor and lead author of the ICN and the IC Optimist magazine, Jill is proud of the academic recognition that her website has achieved. The University of London rated the ICN as the top IC website for accuracy, credibility, readability and quality. (Int Urogynecol J - April 2013). Harvard Medical School rated both Medscape and the ICN as the top two websites dedicated to IC. (Urology - Sept 11). Jill currently serves on the Congressionally Directed Medical Research Panel (US Army) where she collaborates with researchers to evaluate new IC research studies for possible funding. Jill has conducted and/or collaborates on a variety of IC research studies on new therapeutics, pain care, sexuality, the use of medical marijuana, menopause and the cost of treatments, shining a light on issues that influence patient quality of life. An IC support group leader and national spokesperson for the past 20 years, she has represented the IC community on radio, TV shows, at medical conferences. She has written hundreds of articles on IC and its related conditions. With a Bachelors Degree in Pharmacology and a Masters in Psychology, Jill was named Presidential Management Intern (aka Fellowship) while in graduate school. (She was unable to earn her PhD due to the onset of her IC.) She spends the majority of her time providing WELLNESS COACHING for patients in need and developing new, internet based educational and support tools for IC patients, including the “Living with IC” video series currently on YouTube and the ICN Food List smartphone app! Jill was diagnosed with IC at the age of 32 but first showed symptoms at the age of 12.